Jinxin Fertility Group Ltd
HKEX:1951

Watchlist Manager
Jinxin Fertility Group Ltd Logo
Jinxin Fertility Group Ltd
HKEX:1951
Watchlist
Price: 2.94 HKD -6.37% Market Closed
Market Cap: 8.1B HKD
Have any thoughts about
Jinxin Fertility Group Ltd?
Write Note

Jinxin Fertility Group Ltd
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jinxin Fertility Group Ltd
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
Jinxin Fertility Group Ltd
HKEX:1951
Note Receivable
ÂĄ56.8m
CAGR 3-Years
-3%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Topchoice Medical Co Inc
SSE:600763
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dian Diagnostics Group Co Ltd
SZSE:300244
Note Receivable
ÂĄ17.6m
CAGR 3-Years
-37%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
Note Receivable
ÂĄ9.1m
CAGR 3-Years
-69%
CAGR 5-Years
-60%
CAGR 10-Years
-25%
No Stocks Found

Jinxin Fertility Group Ltd
Glance View

Market Cap
8.1B HKD
Industry
Health Care

Jinxin Fertility Group Ltd. engages in the provision of assisted reproductive, management and ancillary medical services. The company is headquartered in Chengdu, Sichuan. The company went IPO on 2019-06-25. The firm operates its business through three segments. The ARS segment primarily provides its patients with two treatment solutions: artificial insemination (AI) and in vitro fertilization (IVF) technology. The Management Services segment provides management services to Jinjiang IVF Center and Jinxin Fertility Center. The Ancillary Medical Services segment mainly provides medical services in the areas of gynecology, urology and internal medicine through Shenzhen Zhongshan Hospital. The firm mainly operates its business in China and the Unites.

Intrinsic Value
4.77 HKD
Undervaluation 38%
Intrinsic Value
Price

See Also

What is Jinxin Fertility Group Ltd's Note Receivable?
Note Receivable
56.8m CNY

Based on the financial report for Dec 31, 2023, Jinxin Fertility Group Ltd's Note Receivable amounts to 56.8m CNY.

What is Jinxin Fertility Group Ltd's Note Receivable growth rate?
Note Receivable CAGR 5Y
-34%

Over the last year, the Note Receivable growth was 45%. The average annual Note Receivable growth rates for Jinxin Fertility Group Ltd have been -3% over the past three years , -34% over the past five years .

Back to Top